Stanley Tennant, Director at Trovagene, Inc. (TROV), bought 10,000 shares at $0.80 ($8K) on 2018-06-08, disclosed to the SEC on 2018-06-13.
Open-market purchase of $8k TROV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| TROV | BUY | 2016-12-19 | $21K | — | Filing → |
| TROV | BUY | 2015-08-12 | $61K | — | Filing → |
| TROV | BUY | 2012-12-03 | $121K | — | Filing → |